Peapack-Gladstone Financial Corp’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Peapack-Gladstone Financial Corp’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$827K	Sell	6,473 -250	-4%	-$31.2K	0.01%	417
2025 Q4	$820K	Hold	6,723	–	–	0.01%	416
2025 Q3	$674K	Sell	6,723 -130	-2%	-$11.7K	0.01%	449
2025 Q2	$568K	Hold	6,853	–	–	0.01%	463
2025 Q1	$556K	Sell	6,853 -375	-5%	-$33.5K	0.01%	467
2024 Q4	$651K	Sell	7,228 -2,135	-23%	-$207K	0.01%	439
2024 Q3	$925K	Sell	9,363 -727	-7%	-$71.4K	0.01%	402
2024 Q2	$935K	Sell	10,090 -880	-8%	-$78.9K	0.01%	403
2024 Q1	$1.04M	Sell	10,970 -645	-6%	-$59.9K	0.02%	391
2023 Q4	$1.04M	Sell	11,615 -1,150	-9%	-$85.4K	0.02%	388
2023 Q3	$932K	Sell	12,765 -360	-3%	-$28.8K	0.02%	393
2023 Q2	$1.09M	Sell	13,125 -680	-5%	-$56.9K	0.02%	380
2023 Q1	$1.14M	Buy	13,805 +340	+3%	+$28.2K	0.02%	368
2022 Q4	$1.12M	Sell	13,465 -292	-2%	-$23.6K	0.02%	354
2022 Q3	$1.09M	Buy	+13,757	New	+$1.16M	0.02%	357

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Peapack-Gladstone Financial Corp's XBI Position: Q1 2026 in Review

Peapack-Gladstone Financial Corp reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 3.7% in Q1 2026, selling an estimated $31.2K and leaving 6,473 shares worth $827K. The position accounts for 0.01% of the portfolio, ranked #417.

Peapack-Gladstone Financial Corp first reported a position in XBI in Q3 2022 and has held it in 15 quarters since. The position peaked at $1.14M in Q1 2023. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Peapack-Gladstone Financial Corp held 6,473 shares of State Street SPDR S&P Biotech ETF worth $827K as of Q1 2026.
Peapack-Gladstone Financial Corp sold 250 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $31.2K.
State Street SPDR S&P Biotech ETF made up 0.01% of Peapack-Gladstone Financial Corp's portfolio in Q1 2026, its #417 holding.
Peapack-Gladstone Financial Corp first reported a position in State Street SPDR S&P Biotech ETF in Q3 2022 and has held it in 15 quarters since.
Peapack-Gladstone Financial Corp's State Street SPDR S&P Biotech ETF position peaked at $1.14M in Q1 2023.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q1 2026, filed 15 May 2026.